bimekizumab
ucb pharmaceuticals
['bimekizumab', 'axspa']
deodhar et al. bimekizumab (il-17a/fi) in nr-axspa. efficacy shown across all outcomes. confirms bimekizumab works across spectrum of axspa (not surprisingly). #acr22 abstr#0544 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC